Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that cardiovascular and metabolic alterations can occur in patients with adrenal adenomas and possible Autonomous Cortisol Secretion (pACS). Investigators hypothesize that adrenalectomy in selected patients, following the 2016 ECE guidelines, can improve metabolic parameters and cardiovascular risks and features.


Clinical Trial Description

Adrenal incidentalomas are clinically silent masses discovered inadvertently during diagnostic imaging procedures performed for unrelated reasons. Depending on the criteria applied, up to 50% of patients with adrenal incidentalomas may have biochemical evidence of cortisol excess. Possible autonomous cortisol secretion (pACS), as defined in the 2016 European Society of Endocrinology Guidelines, is characterized by a partial, incomplete suppression of the hypothalamic-pituitary-adrenal (HPA) axis without the typical signs of overt cortisol hypersecretion. Investigators will perform a prospective longitudinal study in patients with adrenal incidentalomas associated with possible autonomous cortisol secretion, aiming to assess the effect of surgical and conservative management on cardiovascular and metabolic features. Data will be detected at baseline, at 1 and at 5 years follow-up to quantitatively identify the different cardiovascular and metabolic alterations in: (1) patients with non-functioning adrenal adenoma; (2) patients with possible autonomous cortisol secretion receiving conservative management; (3) patients with possible autonomous cortisol secretion receiving adrenalectomy according to the 2016 European Society of Endocrinology guidelines; (4) patients without adrenal masses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04127552
Study type Observational
Source University of Roma La Sapienza
Contact
Status Recruiting
Phase
Start date January 2, 2019
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06050057 - Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
Completed NCT06330558 - Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.
Completed NCT04071561 - Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions
Recruiting NCT06229405 - Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
Not yet recruiting NCT04432532 - Neuroendocrine and Adrenal Tumors
Completed NCT00454103 - Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy Phase 1/Phase 2
Completed NCT03469102 - 18FDG PET Textural Indices in Adrenal Lesion
Completed NCT01959711 - Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy Phase 4
Recruiting NCT04905706 - 3D Laparoscopic Adrenalectomies for Adrenal Tumors
Completed NCT03830593 - Laparoscopic Adrenalectomy for Large Adrenal Tumors.
Recruiting NCT05739812 - The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery N/A
Completed NCT03739918 - Rare Cystic Benign Adrenal Incidentalomas
Completed NCT04804163 - Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery Early Phase 1
Completed NCT03327142 - EUS-guided FNA in the Study of the Adrenal Gland N/A
Completed NCT04570176 - Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System N/A